Systemic Immune-Inflammation Index May Predict the Development of Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction.
Angiology, vol.73, no.3, pp.218-224, 2022 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 73 Issue: 3
- Publication Date: 2022
- Doi Number: 10.1177/00033197211030053
- Journal Name: Angiology
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, Food Science & Technology Abstracts, MEDLINE
- Page Numbers: pp.218-224
- Keywords: systemic immune-inflammation index, contrast-induced nephropathy, ST-segment elevation myocardial infarction, PERCUTANEOUS CORONARY INTERVENTION, ACUTE-RENAL-FAILURE, EUROPEAN-SOCIETY, RISK SCORE, KIDNEY, MEDIA
- Süleyman Demirel University Affiliated: Yes
Abstract
The aim of this study was to investigate the predictive capacity of a systemic immune-inflammation index (SII) in the detection of contrast-induced nephropathy (CIN) following ST-segment elevation myocardial infarction (STEMI). A total of 477 STEMI patients were enrolled in the study. The patients were divided into 2 groups according to CIN development. A cutoff point of 5.91 for logarithm-transformed SII was identified with 73.0% sensitivity and 57.5% specificity to predict CIN following STEMI. According to a pairwise analysis of receiver operating characteristic curve analysis, the predictive power of SII in detecting CIN following STEMI was similar to that of high-sensitivity C-reactive protein and better than the neutrophil/lymphocyte ratio or platelet/lymphocyte ratio. As a result, SII can be used as one of the independent predictors of CIN after STEMI.